Literature DB >> 1427382

Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A.

J A Viedma1, M Pérez-Mateo, J E Domínguez, F Carballo.   

Abstract

Plasma values of immunoreactive interleukin-6, C-reactive protein and phospholipase A have been determined in serial samples from 24 patients with acute pancreatitis ('mild' pancreatitis nine, 'severe' pancreatitis 15). Median plasma concentrations of interleukin-6, C-reactive protein, and phospholipase A activity were significantly higher in patients with 'severe' illness (p < 0.001) than those with 'mild' illness. A particularly marked increase in interleukin-6 was found in two patients with necrotising pancreatitis and fatal outcome. Significant correlations between plasma concentrations of interleukin-6 and phospholipase A (p = 0.0218) and C-reactive protein and phospholipase A activity (p < 0.0001) were found in patients with 'severe' disease. These findings in a limited number of patients with acute pancreatitis are promising in that raised interleukin-6 correlated with clinical severity and with two other established markers, C-reactive protein, and phospholipase A activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1427382      PMCID: PMC1379499          DOI: 10.1136/gut.33.9.1264

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  Training of counsellors on sickle-cell disorders in Africa.

Authors:  O O Akinyanju; E N Anionwu
Journal:  Lancet       Date:  1989-03-25       Impact factor: 79.321

2.  Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapse.

Authors:  P Vadas; W Pruzanski; E Stefanski; B Sternby; R Mustard; J Bohnen; I Fraser; V Farewell; C Bombardier
Journal:  Crit Care Med       Date:  1988-01       Impact factor: 7.598

3.  Interleukin-1 induces interleukin-6 production in peripheral blood monocytes.

Authors:  G Tosato; K D Jones
Journal:  Blood       Date:  1990-03-15       Impact factor: 22.113

4.  IL-1 stimulates IL-6 production in endothelial cells.

Authors:  M Sironi; F Breviario; P Proserpio; A Biondi; A Vecchi; J Van Damme; E Dejana; A Mantovani
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

5.  Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases.

Authors:  J Varani; I Ginsburg; L Schuger; D F Gibbs; J Bromberg; K J Johnson; U S Ryan; P A Ward
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

6.  Experimental acute pancreatitis induced by platelet activating factor in rabbits.

Authors:  G Emanuelli; G Montrucchio; E Gaia; L Dughera; G Corvetti; L Gubetta
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

7.  Modified photometric method for the determination of phospholipase A activities.

Authors:  G E Hoffmann; U Neumann
Journal:  Klin Wochenschr       Date:  1989-02-01

8.  Leukotrienes as mediators in tissue trauma.

Authors:  C Denzlinger; S Rapp; W Hagmann; D Keppler
Journal:  Science       Date:  1985-10-18       Impact factor: 47.728

9.  C reactive protein: an aid to assessment and monitoring of acute pancreatitis.

Authors:  A D Mayer; M J McMahon; M Bowen; E H Cooper
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

10.  Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8.

Authors:  F Bazzoni; M A Cassatella; F Rossi; M Ceska; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  38 in total

1.  Can serum interleukin-6 levels predict the outcome of patients with right iliac fossa pain?

Authors:  A T Goodwin; R I Swift; M J Bartlett; B S Fernando; S J Chadwick
Journal:  Ann R Coll Surg Engl       Date:  1997-03       Impact factor: 1.891

2.  Immunomodulation in surgical practice.

Authors:  R Andersson; B Andersson; E Andersson; G Eckerwall; M Nordén; B Tingstedt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

3.  Acute pancreatitis--from cellular signalling to complicated clinical course.

Authors:  Roland Andersson; Bodil Andersson; Ellen Andersson; Jakob Axelsson; Gunilla Eckerwall; Bobby Tingstedt
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 4.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Authors:  C Dervenis; C D Johnson; C Bassi; E Bradley; C W Imrie; M J McMahon; I Modlin
Journal:  Int J Pancreatol       Date:  1999-06

5.  Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice.

Authors:  J L Van Laethem; R Eskinazi; H Louis; F Rickaert; P Robberecht; J Devière
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

6.  The soluble interleukin-2 receptor, peripheral blood, and reticulocyte fractions in acute pancreatitis.

Authors:  T Salomone; P Boni; C Serra; A M Morselli-Labate; A L Di Gioia; M Romboli; A Guariento
Journal:  Int J Pancreatol       Date:  1996-12

7.  Cerulein pancreatitis: oxidative stress, inflammation, and apoptosis.

Authors:  Hyeyoung Kim
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

8.  Soluble triggering receptor expressed on myeloid cells in severe acute pancreatitis: a biological marker of infected necrosis.

Authors:  Zheng Lu; Yan Liu; Yuan-hang Dong; Xian-bao Zhan; Yi-qi Du; Jun Gao; Yan-fang Gong; Zhao-shen Li
Journal:  Intensive Care Med       Date:  2011-10-27       Impact factor: 17.440

9.  Increased nitric oxide activity in a rat model of acute pancreatitis.

Authors:  R A Al-Mufti; R C Williamson; R T Mathie
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

10.  IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality.

Authors:  Hong Zhang; Patrick Neuhöfer; Liang Song; Björn Rabe; Marina Lesina; Magdalena U Kurkowski; Matthias Treiber; Thomas Wartmann; Sara Regnér; Henrik Thorlacius; Dieter Saur; Gregor Weirich; Akihiko Yoshimura; Walter Halangk; Joseph P Mizgerd; Roland M Schmid; Stefan Rose-John; Hana Algül
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.